Screener
DBV Technologies DBVT VIASKIN® Peanut — Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DBV Technologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.
- Filed
- Jul 16, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-048453
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Clinical studies | 9.9 | 16.3 | 21.3 | 23.1 |
| BLA & Regulatory | 5.6 | 2.3 | 11.9 | 3.7 |
| Medical Affairs & Other Medical | 5.1 | 2.0 | 10.0 | 4.0 |
| Research & Innovation | 0.8 | 0.3 | 1.1 | 1.1 |
| Manufacturing & Supply and Quality | 9.9 | 12.8 | 20.4 | 23.4 |
| Sales & Marketing | 5.5 | 0.4 | 10.4 | 0.7 |
| General & Administrative | 14.6 | 8.5 | 25.1 | 14.1 |
| Total expenses | 51.3 | 42.6 | 100.1 | 70.0 |
Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of
FAQ
- What is DBV Technologies's VIASKIN® peanut — operating expenses?
- DBV Technologies (DBVT) reported VIASKIN® peanut — operating expenses of $51.3M in Q2 2026.
- How has DBV Technologies's VIASKIN® peanut — operating expenses changed year-over-year?
- DBV Technologies's VIASKIN® peanut — operating expenses increased by 20.4% year-over-year, from $42.6M to $51.3M.
- What is the long-term trend for DBV Technologies's VIASKIN® peanut — operating expenses?
- Over 2 years (2023 to 2025), DBV Technologies's VIASKIN® peanut — operating expenses has grown at a 28.7% compound annual growth rate (CAGR), from $92.16M to $152.75M.
- What does VIASKIN® peanut — operating expenses mean?
- The aggregate of all costs associated with the operation of the Viaskin Peanut segment, including research, development, clinical trials, and administrative support. This metric serves as a comprehensive measure of the cash burn rate required to maintain the segment's development pipeline. It is essential for assessing the financial sustainability of the product's lifecycle.
Ask your AI about DBV Technologies's viaskin® peanut — operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude